These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 20407811)

  • 1. Molecular basis of autosomal recessive chronic granulomatous disease in iran.
    Teimourian S; de Boer M; Roos D
    J Clin Immunol; 2010 Jul; 30(4):587-92. PubMed ID: 20407811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three novel mutations in CYBA among 22 Iranians with Chronic granulomatous disease.
    Badalzadeh M; Tajik S; Fazlollahi MR; Houshmand M; Fattahi F; Alizadeh Z; Movahedi M; Adab Z; Khotaei GT; Hamidieh AA; Heidarnazhad H; Pourpak Z
    Int J Immunogenet; 2017 Dec; 44(6):314-321. PubMed ID: 28941186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autosomal recessive chronic granulomatous disease caused by novel mutations in NCF-2, the gene encoding the p67-phox component of phagocyte NADPH oxidase.
    Noack D; Rae J; Cross AR; Muñoz J; Salmen S; Mendoza JA; Rossi N; Curnutte JT; Heyworth PG
    Hum Genet; 1999 Nov; 105(5):460-7. PubMed ID: 10598813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of autosomal recessive chronic granulomatous disease caused by a defect of the nicotinamide adenine dinucleotide phosphate (reduced form) oxidase component p67-phox.
    Patiño PJ; Rae J; Noack D; Erickson R; Ding J; de Olarte DG; Curnutte JT
    Blood; 1999 Oct; 94(7):2505-14. PubMed ID: 10498624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic paradigm for evaluation of male patients with chronic granulomatous disease, based on the dihydrorhodamine 123 assay.
    Jirapongsananuruk O; Malech HL; Kuhns DB; Niemela JE; Brown MR; Anderson-Cohen M; Fleisher TA
    J Allergy Clin Immunol; 2003 Feb; 111(2):374-9. PubMed ID: 12589359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistical and mutational analysis of chronic granulomatous disease in Japan with special reference to gp91-phox and p22-phox deficiency.
    Ishibashi F; Nunoi H; Endo F; Matsuda I; Kanegasaki S
    Hum Genet; 2000 May; 106(5):473-81. PubMed ID: 10914676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Modalities Based on Flow Cytometry for Chronic Granulomatous Disease: A Multicenter Study in a Well-Defined Cohort.
    Baris HE; Ogulur I; Akcam B; Kiykim A; Karagoz D; Saraymen B; Akgun G; Eltan SB; Aydemir S; Akidagi Z; Bentli E; Nain E; Kasap N; Baser D; Altintas DU; Camcioglu Y; Yesil G; Ozen A; Koker MY; Karakoc-Aydiner E; Baris S
    J Allergy Clin Immunol Pract; 2020; 8(10):3525-3534.e1. PubMed ID: 32736065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (second update).
    Roos D; Kuhns DB; Maddalena A; Bustamante J; Kannengiesser C; de Boer M; van Leeuwen K; Köker MY; Wolach B; Roesler J; Malech HL; Holland SM; Gallin JI; Stasia MJ
    Blood Cells Mol Dis; 2010 Apr; 44(4):291-9. PubMed ID: 20167518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four novel mutations in the gene encoding gp91-phox of human NADPH oxidase: consequences for oxidase assembly.
    Leusen JH; Meischl C; Eppink MH; Hilarius PM; de Boer M; Weening RS; Ahlin A; Sanders L; Goldblatt D; Skopczynska H; Bernatowska E; Palmblad J; Verhoeven AJ; van Berkel WJ; Roos D
    Blood; 2000 Jan; 95(2):666-73. PubMed ID: 10627478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematologically important mutations: The autosomal forms of chronic granulomatous disease (third update).
    Roos D; van Leeuwen K; Hsu AP; Priel DL; Begtrup A; Brandon R; Rawat A; Vignesh P; Madkaikar M; Stasia MJ; Bakri FG; de Boer M; Roesler J; Köker N; Köker MY; Jakobsen M; Bustamante J; Garcia-Morato MB; Shephard JLV; Cagdas D; Tezcan I; Sherkat R; Mortaz E; Fayezi A; Shahrooei M; Wolach B; Blancas-Galicia L; Kanegane H; Kawai T; Condino-Neto A; Vihinen M; Zerbe CS; Holland SM; Malech HL; Gallin JI; Kuhns DB
    Blood Cells Mol Dis; 2021 Dec; 92():102596. PubMed ID: 34547651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients.
    Köker MY; Camcıoğlu Y; van Leeuwen K; Kılıç SŞ; Barlan I; Yılmaz M; Metin A; de Boer M; Avcılar H; Patıroğlu T; Yıldıran A; Yeğin O; Tezcan I; Sanal Ö; Roos D
    J Allergy Clin Immunol; 2013 Nov; 132(5):1156-1163.e5. PubMed ID: 23910690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes, renal and cardiovascular disease in p47 phox-/- chronic granulomatous disease.
    Leiding JW; Marciano BE; Zerbe CS; Deravin SS; Malech HL; Holland SM
    J Clin Immunol; 2013 May; 33(4):725-30. PubMed ID: 23386289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second Report of Chronic Granulomatous Disease in Jordan: Clinical and Genetic Description of 31 Patients From 21 Different Families, Including Families From Lybia and Iraq.
    Bakri FG; Mollin M; Beaumel S; Vigne B; Roux-Buisson N; Al-Wahadneh AM; Alzyoud RM; Hayajneh WA; Daoud AK; Shukair MEA; Karadshe MF; Sarhan MM; Al-Ramahi JAW; Fauré J; Rendu J; Stasia MJ
    Front Immunol; 2021; 12():639226. PubMed ID: 33746979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Missense mutations in the gp91-phox gene encoding cytochrome b558 in patients with cytochrome b positive and negative X-linked chronic granulomatous disease.
    Kaneda M; Sakuraba H; Ohtake A; Nishida A; Kiryu C; Kakinuma K
    Blood; 1999 Mar; 93(6):2098-104. PubMed ID: 10068684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and biochemical background of chronic granulomatous disease.
    Jurkowska M; Bernatowska E; Bal J
    Arch Immunol Ther Exp (Warsz); 2004; 52(2):113-20. PubMed ID: 15179325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional analysis of NADPH oxidase in granulocytic cells expressing a delta488-497 gp91(phox) deletion mutant.
    Yu L; Cross AR; Zhen L; Dinauer MC
    Blood; 1999 Oct; 94(7):2497-504. PubMed ID: 10498623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and molecular findings of 38 Iranian patients with chronic granulomatous disease caused by p47-phox defect.
    Tajik S; Badalzadeh M; Fazlollahi MR; Houshmand M; Bazargan N; Movahedi M; Mahlouji Rad M; Mahdaviani SA; Mamishi S; Khotaei GT; Mansouri D; Zandieh F; Pourpak Z
    Scand J Immunol; 2019 Jul; 90(1):e12767. PubMed ID: 30963593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation at histidine 338 of gp91(phox) depletes FAD and affects expression of cytochrome b558 of the human NADPH oxidase.
    Yoshida LS; Saruta F; Yoshikawa K; Tatsuzawa O; Tsunawaki S
    J Biol Chem; 1998 Oct; 273(43):27879-86. PubMed ID: 9774399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional analysis of two-amino acid substitutions in gp91 phox in a patient with X-linked flavocytochrome b558-positive chronic granulomatous disease by means of transgenic PLB-985 cells.
    Bionda C; Li XJ; van Bruggen R; Eppink M; Roos D; Morel F; Stasia MJ
    Hum Genet; 2004 Oct; 115(5):418-27. PubMed ID: 15338276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic granulamatous disease: Two decades of experience from a paediatric immunology unit in a country with high rate of consangineous marriages.
    Kutukculer N; Aykut A; Karaca NE; Durmaz A; Aksu G; Genel F; Pariltay E; Cogulu Ö; Azarsız E
    Scand J Immunol; 2019 Feb; 89(2):e12737. PubMed ID: 30506560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.